Xiaoliang Zhao
Binshui Road
Tianjin, China
Tianjin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Immune checkpoint inhibitors have limited efficacy in SMARCA4-deficient non-small cell lung cancer.
Journal: Translational lung cancer research
Published: August 07, 2025
Perioperative penpulimab-based combination therapy in patients with resectable non-small cell lung cancer (ALTER-L043): an open-label, multicenter, randomized, phase II trial.
Journal: Signal transduction and targeted therapy
Published: July 25, 2025
Artery-leading segmentectomy: a novel "AIDVB" (Artery-priority, Inflation/deflation, Vein/Bronchus): a cross-sectional study.
Journal: International journal of surgery (London, England)
Published: March 03, 2025
Aumolertinib plus chemotherapy as first-line treatment for advanced NSCLC with EGFR exon 19 deletion or exon 21 L858R: a phase II trial.
Journal: The oncologist
Published: April 15, 2024
Wee1 epigenetically modulates H2B mono-ubiquitination at K120 lysine and DNA double-strand break repair through phosphorylation of H2BY37-dependent manner in small-cell lung cancer.
Journal: Thoracic cancer
Published: February 07, 2023
Prognostic significance of 4R lymph node dissection in patients with right primary non-small cell lung cancer.
Journal: World journal of surgical oncology
Published: April 08, 2022
Case Report: Sarcoid-Like Reactions and Tertiary Lymphoid Structures Following Dual Checkpoint Inhibition in a Patient with Early-Stage Lung Adenocarcinoma.
Journal: Frontiers in immunology
Published: October 13, 2021
The Role of Neutrophil-to-Lymphocyte Ratio in Predicting Pathological Response for Resectable Non-Small Cell Lung Cancer Treated with Neoadjuvant Chemotherapy Combined with PD-1 Checkpoint Inhibitors.
Journal: Cancer research and treatment
Published: September 08, 2021
Arginase Pathway Markers of Immune-Microenvironment in Thymic Epithelial Tumors and Small Cell Lung Cancer.
Journal: Clinical lung cancer
Published: February 20, 2021
The Prognostic Value of Non-Predominant Micropapillary Pattern in a Large Cohort of Resected Invasive Lung Adenocarcinoma Measuring ≤3 cm.
Journal: Frontiers in oncology
Published: January 23, 2021
CITED4 enhances the metastatic potential of lung adenocarcinoma.
Journal: Thoracic cancer
Published: December 05, 2020
Last Updated: 09/26/2026